Page 152 - Case Lab Case Analysis

MYLAN AND ETHICS

Mylan has struggled to repair its tarnished image as the

derision of consumers, the media and regulators
continued unabated.

The question however, is probably more basic - how
Mylan didn’t see this coming? After all it was based on

raising their prices by:

• Taking advantage of having a monopoly position.

• The product was unchanged therefore no reason

behind the price increases.
• This product is needed for people who have severe

allergic reactions.

• This product is not a “want” this product is a need.

Person may need this product to essentially save their
life.

The Wall Street Journal, which reported that Mylan low-

balled its calculation of EpiPen profits to Congress by

applying a misleading tax rate suggested the company’s
profits were about 60 percent higher than what Bresch told